Clinical Trials Browser

Not yet recruiting × Uveal Melanoma × Ipilimumab × Clear all

NCT07501117 2026-03-30

Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma

Phase 1 Not yet recruiting

Uveal Melanoma